X0708
D
LIVE
0001958777
FibroBiologics, Inc.
9350 KIRBY DRIVE
SUITE 300
HOUSTON
TX
TEXAS
77054
281-671-5150
DELAWARE
FibroBiologics LLC
Fibrobiologics, Inc.
FibroBiologics Inc.
Corporation
true
2021
Pete
O'Heeron
9350 Kirby Drive
Suite 300
Houston
TX
TEXAS
77054
Executive Officer
Director
Robert
Hoffman
9350 Kirby Drive
Suite 300
Houston
TX
TEXAS
77054
Director
Matthew
Link
9350 Kirby Drive
Suite 300
Houston
TX
TEXAS
77054
Director
Victoria
Niklas
9350 Kirby Drive
Suite 300
Houston
TX
TEXAS
77054
Director
Richard
C.
Cilento
9350 Kirby Drive
Suite 300
Houston
TX
TEXAS
77054
Director
Jason
D.
Davis
9350 Kirby Drive
Suite 300
Houston
TX
TEXAS
77054
Executive Officer
Chief Financial Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2026-06-25
false
true
true
false
0
H.C. Wainwright & Co., LLC
000000375
None
None
430 Park Avenue
3rd Floor
New York
NY
NEW YORK
10022
NY
NEW YORK
false
3000000
3000000
0
Includes pre-funded warrants ($0.0001 exercise price per share) and Series A and Series B common stock purchase warrants ($0.735 exercise price per share), each exercisable for up to 4,081,663 shares of common stock.
false
1
315000
0
Represents a 7% fee; a 1% management fee; reimbursement of non-accountable expenses of $25,000 and legal fees of $50,000; and placement agent warrants to purchase 285,714 shares (exercise price of $0.9188 per share).
0
The issuer intends to use the net proceeds from this offering for working capital and general corporate purposes.
false
FibroBiologics, Inc.
/s/ Ruben A. Garcia
Ruben A. Garcia
General Counsel
2026-06-29